# Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm Delivery

> **NCT01796522** · PHASE3 · WITHDRAWN · sponsor: **Instituto de Investigacion Sanitaria La Fe**

## Conditions studied

- Preterm Delivery.

## Interventions

- **DRUG:** progesterone 200 mg / day vaginally
- **DRUG:** nifedipine (60 mg / day orally)

## Key facts

- **NCT ID:** NCT01796522
- **Lead sponsor:** Instituto de Investigacion Sanitaria La Fe
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** have been published new studies that it showed the ineffectiveness of the treatments proposed in this study.
- **Last updated:** 2015-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01796522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01796522, "Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm Delivery". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01796522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*